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Abstract 
We describe the cloning, expression and purification of the bovine XM866409 form 
of pyroglutamyl-aminopeptidase I. The amino acid sequence, deduced from the 
nucleotide sequence, revealed that it consists of 209 amino acid residues and showed 
to have 98% homology with the human AJ278828 form of the enzyme. Three amino 
acid residues at positions 81, 205 and 208 were found to vary among the two 
sequences. The bovine enzyme was expressed in XL10-gold Esherichia coli cells. 
Immobilizied Ni-ion affinity chromatography was used to purify the expressed protein 
resulting in a yield of 3.3mg of PAP1 per litre culture. The purified enzyme had a 
specific activity of 1700 units/ml. SDS-PAGE produced a single band for bovine 
PAP1 with a molecular weight of ~23-24 kDa which is in good agreement with 
previously reported data on PAP1. Kinetic constants Km and Kcat were 59µΜ and 
3.5s-1, respectively. It possessed an optimum pH between 9-9.5, a temperature of 
37°C and showed an absolute requirement for a thiol-reducing agent (10mM DTT). 
EDTA didn’t prove to have an effect on enzyme activity. Competitive inhibition was 
seen with pyroglutamyl peptides pGlu-His-Pro-NH2 (TRH; Ki= 44.1 uM), pGlu-Ala-
OH (Ki=141 uM) and pGlu-Val-OH (Ki=652.17). 
 
 
 
 
 
 
 
 
 
Introduction 
 
Pyroglutamyl aminopeptidase (PAP ; EC 3.4.19.3) type 1 is an omega peptidase that 
has the ability to remove/hyrolyse pyroglutamic acid (pGlu) from the amino-terminus 
of biologically active peptides and proteins with an apparent specificity for l-pGlu-L-
amino acid optical isomers. The enzymatic activity has been reported to be widely 
present in several bacteria, plants, and animal tissues [1,2,3,4 and 5]. PAP I is 
typically a monomeric cysteine peptidase with a low relative molecular mass (average 
23 kDa), a soluble or cytosolic location, and a pH optimum between 6.5 and 8.0 (see 
Cummins and O’Connor for review [6]). Barrett and Rawlings suggest that the 
cysteine peptidases have come from at least seven different evolutionary origins, each 
of which has produced a sub-group with distinctive structures and properties but 
almost all depend for activity on catalytic dyads of cysteine and histidine [7]. 
Pyroglutamyl aminopeptidase peptidase I (C15) is the sole member of their Clan CF. 
PAP 1 has been shown to have the ability to degrade/inactivate a broad spectrum of 
pGlu-containing peptides including Thyrotropin Releasing Hormone (TRH), 
Luteinizing Hormone Releasing Hormone (LH-RH), Bombesin, Neurotensin, the 
Anorexogenic peptide and Gastrins. Despite its broad substrate specificity, however, 
PAP I is highly specific for N-terminal pGlu residues.  
While the mammalian PAP1s have been implicated in the regulation of neuropeptide 
activity (e.g. the TRH pathway [10] and the neurotensin system [11]) the exact nature 
of the physiological role of PAP I still remains unclear. Within the human brain the 
highest PAP1 activity was found in the cortices with the lowest in the cerebellum [10] 
. Falkous and co-workers have observed significantly increased levels of PAP I in the 
spinal cord of patients suffering from motor neuron disease and that PAP I from 
human cerebral cortex is extremely susceptible to inhibition by potentially neurotoxic 
metal ions [11]. Faivre-Bauman and coworkers [12] showed that addition of specific 
inhibitors of PAP I and Prolyl Endopeptidase (EC 3.4.21.26) to TRH-synthesizing 
hypothalamic cells in primary culture results in a significant increase in both their 
TRH content and in the amount of TRH being released from these cells.  
Recent studies carried out with the aid of a chemically synthesised TRH analogue 
(which is resistant to PAP degradation) have indicated a ‘neuromodulating’ role for 
the PAPs as they can control the formation of cyclo(His-Pro) from TRH [13]. 
Yoshimoto et al. [14] have cloned the gene for the B. amyloliquifaciens enzyme and, 
following its expression in Escherichia coli, have shown that the recombinant enzyme 
appears to exist as a dimer, suggesting differences between the recombinant and wild 
type forms of the enzyme. Other studies indicate that the recombinant PAPs from B. 
subtilis and S. pyogenes are probably tetramers, whilst the recombinant PP from P. 
fluorescens appears to be dimeric in nature [6]. 
The first documented crystallized structure of PAP 1 from Bacillus amyloliquefaciens, 
was viewed at 1.6 A resolution and was documented as folding in an α/β globular 
domain with a hydrophobic core consisting of a twisted β sheet surrounded by five α 
helices. This structure allows the function of most of the conserved residues in the PPI 
family to be identified, and it has been concluded that the catalytic triad consists of 
Cys144, His168 and Glu 81[15]. Ito and co-workers,using X-ray crystallography and 
site-directed mutagenesis, have shown that the molecular recognition of pyroglutamic 
acid is achieved through two hydrogen bonds and an insertion in a hydrophobic 
pocket where, Phe10 is more important to the hydrophobic interaction than Phe142 with 
Phe13 serving as an "induced fit" mechanism [16]. 
 
 
Methods and Materials 
 
Strains, plasmids and enzymes 
The E.coli strain XL10-Gold (Invitrogen) was for cloning experiments and protein 
expression. The plasmid vectors pCR2.1 (Invitrogen) was used for cloning and 
amplification of rBosT-pap1 cDNA and the plasmids pQE-60 (Qiagen) and  pKK223-
3 (Amersham Pharmacia) were used for protein expression. Restriction enzymes, 
REDTaq DNA polymerase, and T4 ligase were purchased from Invitrogen and were 
used according to suppliers recommendations. 
 
Chemicals 
Bovine brain tissue samples were obtained from Keypak, Clonee, Co Meath, Ireland. 
Oligonucleotides were purchased from MWG Biotech AG, Germany. Luria-Bertani 
(LB) broth media was obtained from the Medical Supply Company, Dublin, Ireland. 
Peptides (pGlu-His-Pro-NH2 ,pGlu-Ala-OH and pGlu-Val-OH) and fluorogenic 
substrate pGlu-AMC were purchased from Bachem, UK. Ni-NTA resin used for 
purification was purchased from Qiagen, UK. All other chemicals, including buffers 
and antibiotics were purchased from Sigma-Aldrich Chemical.  
 
Isolation of RNA 
RNA was isolated using Trizol Reagent (Invitrogen), a mono-phasic solution of phenol 
and guanidine isothiocyanate.100 mg of bovine brain tissue was homogenised in 1 ml 
of Trizol reagent using a glass-Teflon homogeniser (treated with RNase AWAY, 
Molecular Bio-Products, inc.) and transferred to a microfuge tube. The sample was 
incubated at room temperature for 5 min to allow complete dissociation of 
nucleoprotein complexes. 200 µl of chloroform was added, mixed by brief vortexing 
and incubated at room temperature for 3 min. The phases were separated by 
centrifugation at 13,000 rpm for 15 min. The upper aqueous layer was transferred to a 
fresh microfuge tube. 500 µl of isopropanol was added and mixed by inversion. The 
sample was incubated at room temperature for 10 min to precipitate the RNA and then 
centrifuged at 13,000 rpm for 10 min. The supernatant was discarded and the RNA 
pellet was washed with 1 ml of 70% ethanol. The RNA pellet was air-dried, dissolved 
in 30 µl RNase-free water and stored at -80°C. 
 
Reverse transcription  
The sequence for the putative bovine pyroglutamyl aminopeptidase 1 gene was 
obtained from the GenBank nucleotide sequence database at NCBI 
(http://www.ncbi.nlm.nih.gov), accession number XM866409. 
1 µg of bovine RNA was combined with 1 µl of 25 µM specific reverse primer 5’ 
CAGCAAGGATCCGTGTTCATGGCAACAGTTG 3’ and the volume made to 5 µl 
with dH2O. The mixture was incubated at 70ºC for 10 min and then placed on ice for 5 
min. Reverse transcription was initiated by adding specific enzyme buffer, a dNTP 
mixture and MMLV reverse transcriptase. The volume was brought to 20 µl with 
dH2O. The first strand was synthesised at 37ºC for 60 min followed by inactivation of 
the transcriptase at 95ºC for 2 min. This was used as template for PCR. 
 
 
Polymerase Chain Reaction 
cDNA was synthesised from total bovine RNA isolated from bovine brain tissue and 
the region encoding the gene was amplified using primers of 5’ 
GAACCCGCCATGGAGCAGCCCAGGAAGGCGG 3’ (forward) and 5’ 
CAGCAAGGATCCGTGTTCATGGCAACAGTTG 3’ (reverse). The polymerase 
chain reaction was performed using a PTC-200 Peltier Thermal Cycler. The PCR 
reaction volume was 50 µl containing 1 µl template (10-100 ng), 1-2.5 mM MgCl2, 
0.5 µM of each primer, 200 µM of each dNTP, 1 unit REDTaq polymerase and 5 µl 
specific 10x enzyme buffer. The parameters for amplification were as follows: 
denaturation at 95°C for 10 min for one cycle, followed by 30 cycles at 95°C for 1 
min, 64.5°C for 30 sec and 72°C for 1 min. A final extension at  72°C for 10 min was 
also included. 
 
Cloning and sequencing  of  the rBosT-pap1 gene  
The amplified DNA was cloned into the TA cloning vector pCR2.1 (pZK1). The gene 
was amplified using gene specific primers 5’ 
GAACCCGCCATGGAGCAGCCCAGGAAGGCGG 3’ (forward primer containing 
the Nco1 restriction site CCATGG) and 5’                      
CAGCAAGGATCCGTGTTCATGGCAACAGTTG 3’ (reverse primer replacing the 
native stop codon with a BamH1 restriction site GGATCC). The gene was restricted 
from this intermediate clone with Nco1 and BamH1 and ligated into the vector pQE60 
(pZK2) resulting in a construct that possessed a 6xHis tag at the 3’ end of the gene 
that was exploited during protein purification. This gene-6xHis construct was sub-
cloned using the pQE-60 encoded EcoR1 and Hind III sites, into the expression vector 
pKK223-3 (PL-Pharmacia) generating the pZK3 expression plasmid (Fig.1). The 
pZK3 plasmid was verified by DNA sequencing (MWG Biotech AG, Germany). 
 
 
 Expression of bovine pyroglutamyl aminopeptidase type 1. 
A 1L volume of Luria-Bertani broth containing ampicillin (100 µg/ml), tetracycline 
(10 µg/ml) and chloramphenicol (25 µg/ml) was inoculated with 10 mls of a 
stationary phase culture of E.coli XL10-Gold (TetR, Δ(µχρΑ)183 Δ(mcrCB-hsdSMR-
mrr)173, endA1, supE44, thi-1, recA1, gyrA96, relA1, lac Hte[F’ proAB 
lacIqZΔΜ15 Tn10(tetR) Amy CamR]) transformed with the PAP1 expression plasmid 
pZK3. Cultures were incubated at 37ºC until an OD600 of 0.35 was reached. For 
induction, IPTG was added to a final concentration of 50 µM. After 4 hours the cells 
were harvested at 4000 rpm for 10 min at 4ºC. The cell pellet was washed with 200 
ml buffer A (50 mM potassium phosphate, pH 8.0) and stored at –20ºC. The cells 
were re-suspended in 50 ml buffer A and disrupted with a 3 mm microtip sonicator 
using 2.5 sec, 40 kHz pulses for 40 sec. The cell debris was removed by 
centrifugation at 4000 rpm for 20 min at 4ºC yielding a crude lysate. 
 
Purification of His-tagged PAP1 
3 ml of Ni-NTA resin was gently mixed with 50 ml of crude lysate for 60 min at 4°C. 
The mixture was poured into a 0.7 x 15 cm column, allowing the resin to settle as the 
liquid passed through. The column was washed four times with 15 ml buffer A 
containing 20 mM imidazole and eluted with 3 x 5 ml fractions buffer A containing 
200 mM imidazole. The elute was dialysed overnight against 1 L buffer A and stored 
at 4 ºC. The purification scheme was analysed by SDS-PAGE. Protein concentration 
was determined by the standard BCA assay and PAP1 activity was determined 
fluorimetrically.  
 
Standard fluorimetric activity assay 
PAP1 activity was determined according to the method by Fujiwara and Tsuru (1978) 
[17], as modified by Browne and O’Cuinn (1983)[18]. The quantitative assay was 
performed in triplicate using 96-well microtitre plates. 25 µl PAP1 sample was 
incubated at 37°C for 15 min with 100 µl pGlu-AMC substrate (final concentration 
250 µM) in buffer A containing, at final concentration: DTT (10 mM), EDTA (2 mM) 
and 5% (v/v) DMSO. The reaction was terminated by the addition of 100 µl 1.5 M 
acetic acid. Negative controls were also included in each assay by adding acetic acid 
to the enzyme prior to the substrate. Liberated AMC was detected using a Perkin 
Elmer LS-50B plate reader spectrophotometer using excitation and emission 
wavelengths of 370 and 440 nm, respectively. The fluorescence readings were 
converted to nanomoles of AMC released per minute using a standard curve of AMC 
prepared under identical assay conditions. 
 
Determination of protein concentration 
All samples were dialysed extensively against ultrapure water prior to assay in order 
to remove interfering substances. Protein was determined by the enhanced 
bicinchoninic acid (BCA) assay based on the method of Smith et al. (1985) [19]. 
Sample (50 µl) was incubated with 200 µl BCA reagent at 37°C for 30 min, after 
which the absorbance at 570nm was determined. BSA was used as a standard for this 
assay. 
 
SDS-PAGE and Zymogram 
Samples were analysed by SDS-PAGE using 15% acrylamide/bis-acrylamide gels (10 
x 12 cm) and stained using 0.25% (w/v) Coomassie blue solution. For zymogram 
analysis, samples were electrophoresed at 4ºC on 15% acrylamide/bis-acrylamide gels 
without SDS. The gels were subsequently incubated for 10 min at 37ºC with buffer A 
containing 5 µM pGlu-AMC and 10 mM DTT. The gel was visualised under UV 
light. 
 
Effect of pH on activity of recombinant pyroglutamyl peptidase 
A pH range 6.0-10.5 was used to observe the effect of pH on PAP1 activity. The 
standard assay was carried out using the following buffers: Buffer A (50 mM 
potassium phosphate, pH 6.0-8.0), buffer B (50 mM Tris/HCl, pH 7.5-9.5) and buffer 
C (50 mM NaOH/glycine, pH 9.5-10.5). PAP1 samples were pre-incubated at 37°C 
for 10 min prior to addition of the substrate solution. 
 
Effect of temperature  
Purified enzyme was assayed in triplicate for 15 minutes at seven different 
temperatures, 4, 22, 30, 37, 40, 50 and 60°C. 
 
Kinetic Studies 
The Michaelis constant (Km) was determined using a range of concentrations of pGlu-
AMC (10-500µM), prepared in buffer A containing at final concentration 10mM DTT 
, 2mM EDTA  and 5% (v/v) DMSO. Purified PAP1 activity was assayed in triplicate 
with each substrate concentration. Km , Vmax (maximal velocity) and  Kcat (turnover 
number) values of PAP1 for the substrate pGlu-AMC were obtained by fitting the 
data to Lineweaver-Burk, Eadie-Hofstee and Hanes-Woolf kinetic models.  These 
parameters were also determined using Enzfitter software from Biosoft, Cambridge, 
UK. Dissociation constant (Ki) was determined for three peptides pGlu-His-Pro-NH2 
(TRH), pGlu-Ala-OH and pGlu-Val-OH using a range of concentrations of pGlu-
AMC (10-300µM), prepared in buffer A containing at final concentration 10mM DTT 
, 2mM EDTA  and 5% (v/v) DMSO. Ki  values were determined using the Lineweaver 
and Burk method. 
 
Results and Discussion 
 
Sequencing of bovine pyroglutamyl peptidase 
The rBos-Pap1 clone which we obtained was subjected to sequencing and compared 
with the human pap1 mammalian sequence available in GenBank AJ278828.The 
680bp DNA fragment (Fig.1) had 71 nucleotides base changes differing from the 
human form. The bovine pap1 sequence encodes proteins of 209 amino acids and 
shows 98% homology with the human pap1 sequence [20].  Three amino acid 
residues at positions 81, 205 and 208 are found to vary among the two sequences 
(Fig.2). Catalytic residues  Glu85, Cys149 and His168 were fully conserved between 
the two sequences which is a common feature with members of the C15 family of 
cysteine peptidases. 
 
Expression and purification of recombinant bovine pyroglutamyl 
aminopeptidase 1 
Competent XL10-Gold E.coli cells were used for expression of bovine pap1. 
Induction for rBos-Pap1 was performed at 37ºC with 0.05mM IPTG for 4 h. Cells 
from the induced culture were harvested, suspended in buffer A, sonicated and 
purified. Purification was carried out as previously described and samples were 
analysed for activity and protein concentration. The purification scheme was 
visualised by SDS-PAGE (Fig.3). SDS-PAGE of recombinant bovine pap1 showed a 
single band with an estimated size of 23kDa. This agrees well to previously reported 
data. [6]. This expression run yielded 3.3mg of bovine PAP1 protein and a specific 
activity of 1700.22 units/mg (Table 1). Zymogram analysis which was carried out on 
the purified preparation showed that purified enzyme was indeed active (Fig.4).   
 
Biochemical characterisation of recombinant bovine pyroglutamyl-peptidase 1 
Effect of pH 
Bovine pap1 displayed an optimum pH of 9.0-9.5 (Fig.5). This compares well with 
data obtained from other researchers which examine the effect of pH on pyroglutamyl 
aminopeptidase activity. Cummins and O’Connor [6] found optimal pH of bovine 
brain to be 8.5 and Dando et al.[20] obtained maximal activity in the range of  pH 7-
9.0 for human pyroglutamyl. Awadé et al. [21] found bacterial pyroglutamyl 
peptidase to display an optimum pH between 7-9.0.  
 
Effect of temperature 
Optimum temperature for bovine pyroglutamyl peptidase activity was obtained at 
37°C (Fig.6). 50% of activity was lost at 50°C and 60°C while 50°C was found to be 
the optimal temperature for human pyroglutamyl peptidase activity [20]. 
 
Effect of DTT and EDTA 
As with all cysteine peptidases [22], there was an absolute requirement for a thiol-
reducing agent for recombinant bovine pyroglutamyl peptidase enzyme activity. 
Optimum activtity was obtained using 10mM DTT (Fig.7). EDTA is thought to have 
a stabilising effect on mammalian pap1 [22, 23], however it did not have any effect on 
bovine pyroglutamyl peptidase activity. 
Kinetics 
The kinetic parameters of purified recombinant bovine pyroglutamyl aminopeptidase 
were determined various methods (Table 2). A Km value of 59 µM was determined for 
the recombinant pyroglutamyl peptidase using various pGlu-AMC substrate 
concentrations ranging between 10 and 500µM. Dando et al. obtained  a Km value of 
50 µM for human pyroglutamyl peptidase.  
Vmax and Kcat values obtained for bovine pyroglutamyl peptidase were 3.15 units/ml 
and 3.5 s-1 respectively. 
A number of pyroglutamyl peptides were tested with the recombinant bovine enzyme 
(Table 3). All of the peptides behaved as competitive inhibitors. TRH produced the 
lowest Ki of 44.117µM, while Ki values for pGlu-Ala-OH and pGlu-Val-OH were 
141µM and 652.17µM respectively. 
 
 
 
Conclusion 
In this study bovine pyroglutamyl aminopeptidase was cloned, expressed and 
purified……………………... 
Bovine pyroglutamyl aminopeptidase displayed typical biochemical properties to that 
of other forms of  PAP1 including human and bacterial. 
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Abbreviations 
PAP1   pyroglutamyl aminopeptidase type 1 
pGlu-AMC  pyroglutamyl-7-amino-4-methyl coumarin 
AMC   7-amino-4-methyl coumarin 
DTT   dithiothreitol 
EDTA   ethylenediaminetetra Acetic Acid 
DMSO              dimethyl sulfoxide 
BSA   bovine serum albumin 
IPTG   Isopropyl-β-D-thiogalactosidase 
Ni-NTA  Nickel Nitrilotriacetic acid 
TRH 
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Fig.1. PCR analysis of bovine pap1 gene by 1% agarose gel. Lane 1 and 8 marker, 
lane 2-7, pap1 DNA. 
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Fig.2. Map of plasmid pZK3 used to express rBosT-pap1 in XL10-Gold cells. The 
construction of this plasmid is described under Materials and methods. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Fig.3. Alignment of the recombinant bovine pyroglutamyl aminopeptidase I amino 
acid sequence with human pyroglutamyl aminopeptidase I AJ278828  highlighting 
the three amino acid variations at positions 81, 205 and 208. The sequences were 
aligned using the Genedoc program. [24]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.4. SDS-PAGE of bovine pyroglutamyl aminopeptidase at each stage of 
purification. Lane 1, protein molecular marker; lane 2, crude supernatant; lane 3, 
flow-through; lane 4-7, sequential column washings; lane 8-10, elution of 
recombinant bovine pyroglutamyl aminopeptidase protein from the column 
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Fig.5. Zymogram analysis of purified bovine pyroglutamyl aminopeptidase high-
lighting activity. 
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Fig.6. Effect of pH on recombinant bovine pyroglutamyl aminopeptidase I activity. 
Enzyme activity was measured under standard assay conditions over the range pH 
6.0-10.5 with buffers as described in materials and methods. The buffers used were ◊, 
potassium phosphate; ○, Tris/HCL and ∆, glycine/NaOH. 
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Fig.7. Effect of temperature on bovine pyroglutamyl aminopeptidase I activity. 
Assays were carried out with substrate pGlu-AMC at 4, 24, 30, 37, 50 and 60°C. 
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Fig.8. Effect of DTT on recombinant bovine pyroglutamyl aminopeptidase I activity. 
Enzyme activity was measured under standard assay conditions using a range of DTT 
concentrations from 0-20mM. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tables 
 
Table1 
Summary of recombinant bovine pyroglutamyl aminopeptidase purification. 
 
 Volume 
ml 
Total Activitya 
Units 
Total Protein 
mg 
Specific Activity 
Units/mg 
 
Purified PAP1 
 
5 
 
5593.783 
 
3.3 
 
1700.22 
 
 
Summary of recombinant bovine pyroglutamyl aminopeptidase purification. a Units = 
nmoles.min-1 i.e. Units are expressed as nanomoles of AMC released per minute at 
37°C. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Table 2 
Kinetic parameters of purified bovine pyroglutamyl aminopeptidase type 1 using 
methods listed below. 
Method Km 
µM 
Vmax  
Units/ml 
Kcat 
s-1 
 
Lineweaver-Burk 
Eadie-Hofstee  
Hanes-Woolf 
Enzfitter Software 
Average 
 
 
66 
55 
50 
63 
59 
 
3.3 
2.93 
3.04 
3.22 
3.12 
 
3.6 
3.25 
3.37 
3.57 
3.5 
 
Enzyme assays were carried out as described in Materials and methods. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3 
Activity of bovine pyroglutamyl aminopeptidase towards pyroglutamyl peptides. 
Peptide Kmapp 
µM 
Ki  
s-1 
Inhibition Type 
 
 
pGlu-His-Pro-NH2  (TRH) 
pGlu-Ala-OH 
pGlu-Val-OH 
 
 
400 
166 
83 
 
44.1 
141 
652.17 
 
C 
C 
C 
Enzyme assays were carried out as described in Materials and methods. C, 
competitive. 
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